"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 17 | 17 |
| 1996 | 0 | 14 | 14 |
| 1997 | 0 | 21 | 21 |
| 1998 | 0 | 18 | 18 |
| 1999 | 0 | 8 | 8 |
| 2000 | 0 | 22 | 22 |
| 2001 | 0 | 30 | 30 |
| 2002 | 0 | 34 | 34 |
| 2003 | 0 | 30 | 30 |
| 2004 | 0 | 34 | 34 |
| 2005 | 0 | 36 | 36 |
| 2006 | 0 | 28 | 28 |
| 2007 | 0 | 55 | 55 |
| 2008 | 0 | 57 | 57 |
| 2009 | 0 | 64 | 64 |
| 2010 | 0 | 65 | 65 |
| 2011 | 0 | 71 | 71 |
| 2012 | 0 | 83 | 83 |
| 2013 | 0 | 78 | 78 |
| 2014 | 0 | 73 | 73 |
| 2015 | 0 | 65 | 65 |
| 2016 | 0 | 95 | 95 |
| 2017 | 0 | 100 | 100 |
| 2018 | 0 | 90 | 90 |
| 2019 | 0 | 107 | 107 |
| 2020 | 0 | 88 | 88 |
| 2021 | 0 | 58 | 58 |
| 2022 | 0 | 15 | 15 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 35 | 35 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
National survey of financial burden and experience among patients with cancer and autoimmune disease receiving charitable copay assistance. Cancer. 2025 Jan 15; 131(2):e35721.
-
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. J Immunother Cancer. 2025 Jan 11; 13(1).
-
Rehabilitation at Home Using Mobile Health for Older Adults Hospitalized for Ischemic Heart Disease: The RESILIENT Randomized Clinical Trial. JAMA Netw Open. 2025 Jan 02; 8(1):e2453499.
-
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers. Cancer. 2025 Jan 01; 131(1):e35680.
-
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
-
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024 Dec; 8:e2400327.
-
Time-restricted eating for prevention of age-related vascular cognitive decline in older adults: A protocol for a single-arm open-label interventional trial. PLoS One. 2024; 19(12):e0314871.
-
Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma. N Engl J Med. 2024 Nov 21; 391(20):1890-1900.
-
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement. Am Heart J. 2025 Feb; 280:79-88.
-
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary. Gynecol Oncol. 2024 Dec; 191:249-258.